Polyethylene Furanoate (PEF) Market to Hit US$ 88.2 Million by 2034, Growing at a 8.3% CAGR | Fact.MR
July 29, 2024 07:00 ET
|
FACT.MR
Rockville, MD., July 29, 2024 (GLOBE NEWSWIRE) -- Revenue from the global Polyethylene Furanoate (PEF) Market is expected to reach US$ 39.7 million in 2024, as revealed in the recently updated...
CorVascular’s VasoGuard® Earns FDA 510(k) Clearance
July 29, 2024 07:00 ET
|
CorVascular
VasoGuard FDA clearance allows CorVascular to immediately begin marketing and selling devices to clinics, hospitals, and teaching institutions across US.
Talisker Announces Private Placement of up to $2 Million
July 29, 2024 07:00 ET
|
Talisker Resources Ltd.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, July 29, 2024 (GLOBE NEWSWIRE) -- Talisker Resources Ltd. (“Talisker” or the “Company”)...
Can-Fite Provides Namodenoson Patent Update
July 29, 2024 07:00 ET
|
Can-Fite BioPharma Ltd.
Broad Protection of Namodenoson is expected till at least 2044 PETACH TIKVA, Israel, July 29, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology...
Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain
July 29, 2024 07:00 ET
|
Rapport Therapeutics, Inc.
BOSTON and SAN DIEGO, July 29, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational...
Amcomri Enters Into Agreement for Sale of Its Film Business
July 29, 2024 07:00 ET
|
Amcomri Entertainment Inc.
VANCOUVER, British Columbia, July 29, 2024 (GLOBE NEWSWIRE) -- Amcomri Entertainment Inc. (“Amcomri” or the “Company”) (Cboe CA: AMEN) (Frankfurt: 25YO) (OTC: AMNNF) today announced that Trinity...
Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
July 29, 2024 07:00 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Provides Enrollment Update for Phase 2 BESTOW Trial Assessing Tegoprubart for the Prevention of Organ Rejection
Attralus Receives European Medicines Agency Committee for Orphan Medicinal Products (COMP) Positive Opinions for AT-02 for the Treatment of Both ATTR and AL Amyloidosis
July 29, 2024 07:00 ET
|
Attralus, Inc
AT-02 has been granted COMP positive opinions for orphan medicinal product designations in the EU for both ATTR and AL amyloidosisAT-02 is the Company’s lead pan-amyloid removal therapeutic candidate...
ECARX Announces Board Change
July 29, 2024 07:00 ET
|
ECARX LIMITED
SHANGHAI, July 29, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced the appointment of Mr. Tao Li as a director...
On July 29, 2024, Decisions of the general extraordinary meeting of shareholders
July 29, 2024 07:00 ET
|
Utenos Trikotazas
AB „Utenos trikotažas“ (hereinafter, the “Company”) dinary of the extraordinary general meeting of shareholders agenda and decisions of the Meeting: Regarding the Company's appeal to the Court with a...